MYB NewsBusiness News
Markets
Business · 1 min read

U.S. government backs Mark Cuban company to develop ibogaine

The Department of Health and Human Services committed up to $4.9 million through ARPA-H for the project.

Glass office towers seen from street level, pointing into a cloudy sky.

The U.S. Department of Health and Human Services announced it is backing the Mark Cuban Cost Plus Drug Company to develop ibogaine for post-traumatic stress disorder, according to Psychedelic Alpha. The agency is committing up to $4.9 million through ARPA-H to fund the work on manufacturing and government approvals.

Beond, a clinic operator, provided data to support the development effort. The project involves collaboration with the Department of Veterans Affairs. Officials also launched a funding opportunity through the National Institute of Mental Health to build a real-world research network.

Reported and written by MYB News.

Figures as reported by Psychedelic Alpha.

Comment

More in business

See all

Comments

Talk business and keep it civil. A complaint about a private person or a local business goes to them first, not here.